Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Turn Therapeutics (TTRX) EPS (Basic) (2024 - 2026)

Turn Therapeutics' quarterly EPS (Basic) came in at -$0.03 in Q1 2026, down 200.0% year-on-year from $0.03 in Q1 2025, and down 400.0% quarter-over-quarter from $0.01 in Q4 2025.

Turn Therapeutics has reported EPS (Basic) for 3 years, with the latest figure at -$0.03 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Basic) fell 200.0% year-over-year to -$0.03; the trailing twelve-month figure through Mar 2026 stood at -$0.1 (changed N/A YoY), and the FY2025 full-year result was -$0.12, down 71.43% from the prior year.
  • EPS (Basic) for Q1 2026 stood at -$0.03, down from $0.01 in the prior quarter.
  • The five-year high for EPS (Basic) was $0.01 in Q4 2025, with the low at -$0.07 in Q3 2025.
  • Average EPS (Basic) over 3 years is -$0.02, with a median of -$0.02 recorded in 2024.
  • Year-over-year, EPS (Basic) surged 150.0% in 2025 and sank 200.0% in 2026.
  • Tracing TTRX's EPS (Basic) over 3 years: stood at -$0.02 in 2024, then surged by 150.0% to $0.01 in 2025, then slumped by 400.0% to -$0.03 in 2026.
  • The last three EPS (Basic) figures came in at -$0.03 (Q1 2026), $0.01 (Q4 2025), and -$0.07 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 3.06
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 0.00
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 0.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 4.06
7 Evaxion A 62.56 Bn 62.54 Bn - 0.00
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 6.99
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.55
10 Turn Therapeutics 188.06 Mn 188.06 Mn - -0.03

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.03
Dec 31, 2025 0.01
Sep 30, 2025 -0.07
Mar 31, 2025 -0.01
Dec 31, 2024 -0.02
Sep 30, 2024 -0.03